Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: positive for Covid 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (positive for Covid 19) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    patient had no underlying conditions.    On 11-Nov-2021, the patient received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (positive for Covid 19). At the time of the report, COVID-19 (positive for Covid 19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.         Concomitant product use was not provided by the reporter.  Patient experienced mild cold like symptoms, headache and cough as symptoms of covid-19.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Company comment: This spontaneous case concerns a 54 year old male patient with no reported medical history, who experienced the unexpected non serious AESI of COVID-19, unknown days after receiving the second dose with mRNA-1273 vaccine in the COVID-19 vaccination series. The patient received the first dose with the same vaccine on an unknown date. The patient received the third dose with Pfizer COVID 19 vaccine. Patient experienced mild cold like symptoms, headache and cough as symptoms of COVID 19. On an unknown date, SARS-CoV-2 test was positive. No further information on risk factors, co morbidities, other investigations and treatment was available in the report. COVID-19 pandemia could be confounding for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a 54 year old male patient with no reported medical history, who experienced the unexpected non serious AESI of COVID-19, unknown days after receiving the second dose with mRNA-1273 vaccine in the COVID-19 vaccination series. The patient received the first dose with the same vaccine on an unknown date. The patient received the third dose with Pfizer COVID 19 vaccine. Patient experienced mild cold like symptoms, headache and cough as symptoms of COVID 19. On an unknown date, SARS-CoV-2 test was positive. No further information on risk factors, co morbidities, other investigations and treatment was available in the report. COVID-19 pandemic could be confounding for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.